Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v28-EN Version v25-FR
Language English French
Date Updated 2018-11-02 2018-11-01
Drug Identification Number 02223716 02223716
Brand name ZITHROMAX - PWS ORL 100MG/5ML ZITHROMAX - PWS ORL 100MG/5ML
Common or Proper name Zithromax Zithromax
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients AZITHROMYCIN AZITHROMYCIN
Strength(s) 100MG 100MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 300mg/15mL 300mg/15mL
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-20 2018-04-20
Estimated end date
Actual end date 2018-11-01 2018-10-31
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments